Story thread · 2 reports / 2 sources
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
financialpost.com · 2h · first report
Binding term sheet with PsyLabs provides Psyence BioMed’s Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs’ pharmaceutical-grade ibogaine, subject to a definitive agreement NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that its wholly-owned Texas subsidiary, Texas Ibogaine Research […]
The coverage
- Psyence BioMed unit signs term sheet for U.S. ibogaine rights
investing.com · 1h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.